newsfilter
← Latest News
GlobeNewswire·

Lumos Pharma Announces Abstract Accepted for Presentation at September Medical Meeting, SLEP 2024

AUSTIN, Texas, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that an updated analysis of data